Bank of Montreal’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39B Sell
1,507,369
-122,082
-7% -$124M 0.52% 38
2025
Q4
$1.75B Buy
1,629,451
+59,534
+4% +$56.9M 0.61% 31
2025
Q3
$1.2B Buy
1,569,917
+127,679
+9% +$95M 0.46% 46
2025
Q2
$1.12B Sell
1,442,238
-81,138
-5% -$63.1M 0.53% 38
2025
Q1
$1.26B Sell
1,523,376
-139,617
-8% -$116M 0.61% 34
2024
Q4
$1.28B Sell
1,662,993
-228,365
-12% -$189M 0.6% 34
2024
Q3
$1.66B Buy
1,891,358
+52,218
+3% +$46.9M 0.73% 27
2024
Q2
$1.67B Buy
1,839,140
+26,158
+1% +$20.9M 0.48% 28
2024
Q1
$1.41B Sell
1,812,982
-103,357
-5% -$73.6M 0.43% 30
2023
Q4
$1.12B Buy
1,916,339
+190,301
+11% +$111M 0.34% 39
2023
Q3
$1.01B Sell
1,726,038
-227,219
-12% -$117M 0.35% 38
2023
Q2
$916M Buy
1,953,257
+311,612
+19% +$131M 0.32% 39
2023
Q1
$564M Sell
1,641,645
-60,852
-4% -$20.5M 0.23% 62
2022
Q4
$624M Buy
1,702,497
+150,173
+10% +$53.2M 0.27% 55
2022
Q3
$513K Sell
1,552,324
-33,669
-2% -$10.7M 0.22% 64
2022
Q2
$508K Buy
1,585,993
+270,379
+21% +$81.2M 0.24% 74
2022
Q1
$382M Sell
1,315,614
-207,425
-14% -$53.4M 0.18% 101
2021
Q4
$423M Sell
1,523,039
-668,859
-31% -$170M 0.22% 90
2021
Q3
$506M Buy
2,191,898
+5,261
+0.2% +$1.3M 0.23% 82
2021
Q2
$501M Buy
2,186,637
+237,688
+12% +$47.7M 0.25% 82
2021
Q1
$356M Sell
1,948,949
-504,859
-21% -$98.8M 0.23% 88
2020
Q4
$456M Buy
2,453,808
+151,543
+7% +$22.6M 0.3% 74
2020
Q3
$332M Sell
2,302,265
-87,683
-4% -$13.6M 0.28% 81
2020
Q2
$398M Sell
2,389,948
-291,503
-11% -$44.7M 0.36% 62
2020
Q1
$381M Sell
2,681,451
-253,450
-9% -$34.8M 0.44% 51
2019
Q4
$386M Sell
2,934,901
-178,144
-6% -$20.6M 0.29% 66
2019
Q3
$348M Sell
3,113,045
-551,892
-15% -$61.4M 0.3% 67
2019
Q2
$406M Sell
3,664,937
-149,419
-4% -$17.6M 0.34% 58
2019
Q1
$495M Sell
3,814,356
-561,716
-13% -$68.3M 0.42% 47
2018
Q4
$506M Buy
4,376,072
+45,418
+1% +$5.07M 0.48% 42
2018
Q3
$465M Buy
4,330,654
+191,374
+5% +$19.1M 0.36% 55
2018
Q2
$353M Sell
4,139,280
-546,661
-12% -$44.9M 0.29% 63
2018
Q1
$363M Buy
4,685,941
+54,700
+1% +$4.4M 0.32% 58
2017
Q4
$391M Buy
4,631,241
+2,133,606
+85% +$182M 0.34% 56
2017
Q3
$214M Buy
2,497,635
+988,698
+66% +$81.1M 0.2% 104
2017
Q2
$124M Buy
1,508,937
+604,577
+67% +$49.3M 0.12% 164
2017
Q1
$76.1M Sell
904,360
-29,225
-3% -$2.34M 0.07% 223
2016
Q4
$62.7M Sell
933,585
-222,432
-19% -$16.6M 0.07% 251
2016
Q3
$92.8M Buy
1,156,017
+57,025
+5% +$4.56M 0.1% 174
2016
Q2
$86.5M Buy
1,098,992
+235,621
+27% +$17.7M 0.1% 178
2016
Q1
$62.2M Sell
863,371
-97,440
-10% -$7.37M 0.07% 213
2015
Q4
$81M Buy
960,811
+141,723
+17% +$11.8M 0.1% 164
2015
Q3
$68.5M Sell
819,088
-37,830
-4% -$3.19M 0.09% 193
2015
Q2
$71.5M Sell
856,918
-58,027
-6% -$4.42M 0.08% 218
2015
Q1
$66.5M Sell
914,945
-28,402
-3% -$2.02M 0.08% 229
2014
Q4
$65.1M Buy
943,347
+13,429
+1% +$906K 0.07% 225
2014
Q3
$60.3M Sell
929,918
-161,338
-15% -$10.2M 0.07% 252
2014
Q2
$67.8M Buy
1,091,256
+175,845
+19% +$10.5M 0.08% 220
2014
Q1
$53.9M Sell
915,411
-105,018
-10% -$5.86M 0.07% 224
2013
Q4
$52M Sell
1,020,429
-636,687
-38% -$31.9M 0.07% 215
2013
Q3
$83.4M Sell
1,657,116
-2,266,646
-58% -$119M 0.13% 138
2013
Q2
$193M Buy
+3,923,762
New +$214M 0.34% 60

Other funds holding LLY

Bank of Montreal's LLY Position: Q1 2026 in Review

Bank of Montreal reduced its Eli Lilly (LLY) stake by 7.5% in Q1 2026, selling an estimated $124M and leaving 1,507,369 shares worth $1.39B. The position accounts for 0.52% of the portfolio, ranked #38.

Bank of Montreal first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.75B in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bank of Montreal held 1,507,369 shares of Eli Lilly worth $1.39B as of Q1 2026.
  • Bank of Montreal sold 122,082 Eli Lilly shares in Q1 2026, an estimated $124M.
  • Eli Lilly made up 0.52% of Bank of Montreal's portfolio in Q1 2026, its #38 holding.
  • Bank of Montreal first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Eli Lilly position peaked at $1.75B in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.